	US 11,890,343 B2
	Medical organogel processes and compositions
Peter Jarrett, Lexington, MA (US); Rami El-Hayek, Norwood, MA (US); and Amarpreet S. Sawhney, Lexington, MA (US)
Assigned to Incept, LLC, Lexington, MA (US)
Filed by Incept, LLC, Lexington, MA (US)
Filed on Dec. 22, 2020, as Appl. No. 17/131,242.
Application 14/926,707 is a division of application No. 13/705,808, filed on Dec. 5, 2012, granted, now 9,205,150, issued on Dec. 8, 2015.
Application 17/131,242 is a continuation of application No. 14/926,707, filed on Oct. 29, 2015, granted, now 10,905,765.
Claims priority of provisional application 61/566,768, filed on Dec. 5, 2011.
Prior Publication US 2021/0177975 A1, Jun. 17, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 47/34 (2017.01); A61K 9/06 (2006.01); A61K 38/38 (2006.01); C07K 16/00 (2006.01); A61K 9/00 (2006.01)

CPC A61K 47/34 (2013.01) [A61K 9/06 (2013.01); A61K 38/38 (2013.01); C07K 16/00 (2013.01); A61K 9/0051 (2013.01)]

19 Claims

1. A process of making a medical material comprising forming an organogel around a powder of a water soluble biologic, with the organogel comprising an organic solvent and with the powder being dispersed in the organogel, wherein the organogel comprises covalently crosslinked hydrophilic polymers and/or ionically crosslinked polymers, wherein the organogel is formed in an absence of aqueous solution.